In Australia, three patients have recently been implanted with the new version VentrAssist
LVA4 under the Special Access Scheme (SAS). The new version features several
enhancements introduced in response to physician feedback. VentrAssist LVA4 will be
introduced in all markets as soon as approval is obtained in response to the regulatory
submissions already made.